Abstract
Purpose
The purpose of the study is to report the clinical case of a 53-year-old woman whose presenting manifestation of primary intraocular lymphoma (PIOL) was unilateral retinal degeneration.
Method
A case report was created with review of clinical, imaging, electrophysiologic, and pathological investigations.
Results
A 53-year-old woman with a distant history of ocular herpes simplex developed progressive central visual loss and intermittent photopsia over 4 years in her right eye. Ophthalmic examination revealed reduced visual acuity OD, central scotoma, and minimal ocular findings. Autofluorescence and infrared imaging revealed mild reflectance changes in the temporal macula, and spectral-domain optical coherence tomography identified mild disruptions of inner segment/outer segment junctions in the subfoveal region of the right eye. A mild window defect was seen on fluorescein angiography. Electrophysiology with multifocal electroretinogram (ERG) revealed evidence of unilateral macular dysfunction. Full-field ERGs revealed progressive global retinal dysfunction over 6 months, with unilateral decreases in amplitude and implicit time shifts, as seen in cases of autoimmune retinopathies. The eye eventually exhibited mild vitreous cellular infiltration on ophthalmoscopic examination, and vitrectomy diagnosed B cell non-Hodgkin’s lymphoma. Further evaluation revealed no evidence of central nervous system or systemic disease, consistent with occult PIOL.
Conclusions
This case illustrates an atypical presentation of PIOL characterized by unilateral retinal disease presenting with symptoms and signs of macular dysfunction. Clinical and ERG features evolved into an acute zonal occult outer retinopathy (AZOOR)-like phenotype. PIOL should be considered in atypical cases of AZOOR with vitreal reactions, and some cases of AZOOR may be related to B cell lymphocyte disorders.
References
Chan CC, Buggage RR, Nussenblatt RB (2002) Intraocular lymphoma. Curr Opin Ophthalmol 13(6):411–418
Levy-Clarke GA, Chan CC, Nussenblatt RB (2005) Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19(4):739–749
Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, Shenkier TN, Siegal T, Doolittle ND, Batchelor T, Herrlinger U, Neuwelt EA, Laperriere N, Chamberlain MC, Blay JY, Ferreri AJ, Omuro AM, Thiel E, Abrey LE (2007) Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol 18(11):1851–1855
Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM, International Society For Clinical Electrophysiology of V (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124(1):1–13
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M, International Society for Clinical Electrophysiology of V (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118(1):69–77
Francis PJ, Marinescu A, Fitzke FW, Bird AC, Holder GE (2005) Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol 89(1):70–73
Jacobson DM, Thirkill CE, Tipping SJ (1990) A clinical triad to diagnose paraneoplastic retinopathy. Ann neurol 28(2):162–167
Audo I, Webster AR, Bird AC, Holder GE, Kidd MN (2006) Progressive retinal dysfunction in diffuse unilateral subacute neuroretinitis. Br J Ophthalmol 90(6):793–794
Yasuda C, Ueno S, Kondo M, Kondo N, Piao CH, Terasaki H (2010) Analyses of ERG in a patient with intraocular lymphoma. Clin Ophthalmol 4:301–306
Gunduz K, Pulido JS, McCannel CA, O’Neill BP (2006) Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus 21(5):E9
Coupland SE, Heimann H, Bechrakis NE (2004) Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 242 (11):901–913
Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N (2003) Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 110(2):421–426
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49(2):146–154
Acknowledgments
AG is funded by the Doris Duke Clinical Research Fellowship for medical students. Imaging is supported by the NEI Core grant 5P30EY019007, NCI Core grant 5P30CA013696, and unrestricted funds from Research to Prevent Blindness, New York, NY. DCH is supported by EY09076. The Bernard and Shirlee Brown Glaucoma Laboratory is supported by R01EY018213, the Foundation Fighting Blindness, Schneeweiss Stem Cell Fund, and the Tistou and Charlotte Kerstan Foundation. SHT is a member of the RD-CURE Consortium, Fellow of the Burroughs-Wellcome Program in Biomedical Sciences and has been supported by the Bernard Becker Association of University Professors in Ophthalmology Research to Prevent Blindness Award, Dennis W. Jahnigen Award of the American Geriatrics Society, Joel Hoffman Scholarship, Barbara and Donald Jonas Family Fund, and Professor Gertrude Rothschild Stem Cell Foundation.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barile, G.R., Garg, A., Hood, D.C. et al. Unilateral retinopathy secondary to occult primary intraocular lymphoma. Doc Ophthalmol 127, 261–269 (2013). https://doi.org/10.1007/s10633-013-9409-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-013-9409-7